(CercleFinance.com) – Bristol Myers Squibb (BMS) will present its research results and its hematology and cell therapy pipeline at the 65th Annual Meeting and Exhibition of the American Society of Hematology (ASH), which will take place in San Diego, California, December 9-12, 2023.
Results from 73 data releases from company-sponsored studies will be presented, including 22 oral presentations, showcasing BMS’ commitment to delivering transformative medicines that help more patients living with blood disorders .
“We look forward to highlighting our continued commitment to unlocking the full promise of cell therapy and our differentiated research platforms, demonstrating the clinical and real-world value of our medicines through our scientific innovation,” said Samit Hirawat, Vice President Executive, Chief Medical Officer, Global Drug Development, Bristol Myers Squibb.
Copyright © 2023 CercleFinance.com. All rights reserved.
Did you like this article ? Share it with your friends using the buttons below.
